Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide Autogel vs Sandostatin LAR for symptoms of carcinoid syndrome
2004-001091-40Phase 3Completed
- Sponsor
- Ipsen
- Start
- Aug 2004
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of lanreotide in Carcinoid Syndrome (CS), sponsored by Ipsen. Started Aug 2004; status: completed.
02
Drugs
lanreotide
03
Conditions
Carcinoid Syndrome (CS)
Beyond the preview
Go deeper on 2004-001091-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001091-40.